Zacks Investment Research on MSN
GSK stock up almost 19% in 3 months: Should you buy, hold or sell?
GSK GSK stock has risen 18.6% in the past three months. The price recovery was backed by strong third-quarter results, ...
If you are wondering whether GSK is still good value after its strong run, you are not alone. This article will walk through ...
TipRanks on MSN
GSK expands share buyback program with recent purchase
GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...
GSK (LSE:GSK) has quietly kept shareholders happy this year, with the stock climbing about 34% year to date and roughly 42% ...
On October 31, JPMorgan lowered its price target on GSK plc (NYSE:GSK) to 1,440 GBp from 1,550 GBp while maintaining an Underweight rating on the stock, according to a report by The Fly. GSK ...
The average one-year price target for GSK (OTCPK:GLAXF) has been revised to $23.15 / share. This is an increase of 11.52% from the prior estimate of $20.76 dated November 9, 2025. The price target is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback